查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
不孕诊断与治疗市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1356790

不孕诊断与治疗市场报告：2030 年趋势、预测与竞争分析

Infertility Diagnosis and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

不孕诊断和治疗的趋势和预测

至2030年，全球不孕诊断和治疗市场预计将达到29亿美元，2024年至2030年年复合成长率为7.9%。市场的主要促进因素是出生率下降、各种不孕治疗方案的可用性增加以及世界各地不孕治疗中心数量的增加。不孕不孕诊断和治疗市场前景广阔，男性和女性不孕治疗市场蕴藏商机。

不孕诊断与治疗市场洞察

  • Lucintel 预测，女性不孕诊断在预测期内将出现高速成长。
  • 女性不孕治疗仍是最大的部分。
  • 由于生活方式的改变和老年人口的增加，北美在预测期内将继续成为最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球不孕诊断与治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球不孕诊断和治疗市场趋势（2018-2023）和预测（2024-2030）
  • 全球不孕诊断和治疗市场（按诊断）
    • 男性不孕的诊断
    • 女性不孕的诊断
  • 按治疗分類的全球不孕诊断与治疗市场
    • 男性不孕治疗
    • 女性不孕治疗
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球不孕诊断与治疗市场（按地区）
  • 北美不孕诊断与治疗市场
  • 欧洲不孕诊断与治疗市场
  • 亚太不孕诊断与治疗市场
  • 其他区域不孕诊断与治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球不孕诊断与治疗市场诊断成长机会
    • 全球不孕诊断和治疗市场成长机会（按治疗）
    • 全球不孕诊断和治疗市场按地区成长机会
  • 全球不孕诊断和治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球不孕诊断和治疗市场的能力
    • 全球不孕诊断和治疗市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea
简介目录

Infertility Diagnosis and Treatment Trends and Forecast

The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets. The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

A more than 150-page report is developed to help in your business decisions.

Infertility Diagnosis and Treatment by Segment

The study includes a forecast for the global infertility diagnosis and treatment by diagnosis, treatment, and region.

Infertility Diagnosis and Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Male Infertility Diagnosis
  • Female Infertility Diagnosis

Infertility Diagnosis and Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Male Infertility Treatment
  • Female Infertility Treatment
  • Others

Infertility Diagnosis and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Infertility Diagnosis and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infertility diagnosis and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infertility diagnosis and treatment companies profiled in this report include-

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea

Infertility Diagnosis and Treatment Market Insights

  • Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.
  • Female infertility treatment will remain the largest segment.
  • North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Features of the Global Infertility Diagnosis and Treatment Market

  • Market Size Estimates: Infertility diagnosis and treatment market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Infertility diagnosis and treatment market size by diagnosis, treatment, and region. in terms of value ($B).
  • Regional Analysis: Infertility diagnosis and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatments, and region.s for the infertility diagnosis and treatment market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infertility diagnosis and treatment market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the infertility diagnosis and treatment market size?

Answer: The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030.

Q.2. What is the growth forecast for infertility diagnosis and treatment market?

Answer: The global infertility diagnosis and treatment market is expected to grow with a CAGR of 7.9% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the infertility diagnosis and treatment market?

Answer: The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

Q.4. What are the major segments for infertility diagnosis and treatment market?

Answer: The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets.

Q.5. Who are the key infertility diagnosis and treatment market companies?

Answer: Some of the key infertility diagnosis and treatment companies are as follows:

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea

Q.6. Which infertility diagnosis and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.

Q.7. In infertility diagnosis and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the infertility diagnosis and treatment market by diagnosis (male infertility diagnosis and female infertility diagnosis), treatment (male infertility treatment, female infertility treatment, and Others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Infertility Diagnosis and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Infertility Diagnosis and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Infertility Diagnosis and Treatment Market by Diagnosis
    • 3.3.1: Male Infertility Diagnosis
    • 3.3.2: Female Infertility Diagnosis
  • 3.4: Global Infertility Diagnosis and Treatment Market by Treatment
    • 3.4.1: Male Infertility Treatment
    • 3.4.2: Female Infertility Treatment
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Infertility Diagnosis and Treatment Market by Region
  • 4.2: North American Infertility Diagnosis and Treatment Market
    • 4.2.2: North American Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.3: European Infertility Diagnosis and Treatment Market
    • 4.3.1: European Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.3.2: European Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.4: APAC Infertility Diagnosis and Treatment Market
    • 4.4.1: APAC Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.4.2: APAC Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.5: ROW Infertility Diagnosis and Treatment Market
    • 4.5.1: ROW Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.5.2: ROW Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Diagnosis
    • 6.1.2: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Infertility Diagnosis and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Infertility Diagnosis and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Infertility Diagnosis and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bayer AG
  • 7.2: Bristol-Myers Squibb
  • 7.3: Church & Dwight
  • 7.4: Cook Medical
  • 7.5: Coopersurgical
  • 7.6: Eli Lilly
  • 7.7: EMD Serono
  • 7.8: Endo Pharmaceuticals
  • 7.9: Ferring Pharmaceuticals
  • 7.10: Genea